Kiilu E, Karanja S, Kikuvi G, Muthoki L
AIDS Behav. 2025; .
PMID: 39953354
DOI: 10.1007/s10461-025-04648-4.
Mitiku A, Yirdaw B, Alem H, Yazie Ferede W, Erega B
SAGE Open Med. 2024; 12:20503121241283347.
PMID: 39529896
PMC: 11552051.
DOI: 10.1177/20503121241283347.
Belachew T, Mitiku A, Tegegne D, Yimer T, Mekuriaw B, Mengistu T
BMJ Open. 2024; 14(10):e086374.
PMID: 39438089
PMC: 11499856.
DOI: 10.1136/bmjopen-2024-086374.
Belachew T, Erega B, Ewunetu M, Gelaye K, Yimer T, Yazie Ferede W
Heliyon. 2024; 10(15):e35319.
PMID: 39161839
PMC: 11332886.
DOI: 10.1016/j.heliyon.2024.e35319.
Audet C, Graves E, Shepherd B, Prigmore H, Brooks H, Emilio A
J Acquir Immune Defic Syndr. 2024; 96(3):259-269.
PMID: 38905476
PMC: 11196005.
DOI: 10.1097/QAI.0000000000003440.
Level of adherence to option B+ program and associated factors among HIV-positive women in Ethiopia: A systematic review and meta-analysis.
Ayele A, Kassa B, Mihretie G, Belay H, Sewyew D, Semahegn A
PLoS One. 2024; 19(4):e0298119.
PMID: 38662634
PMC: 11045077.
DOI: 10.1371/journal.pone.0298119.
Adherence to option B + antiretroviral therapy and associated factors in pregnant and breastfeeding women in Sub-Saharan Africa: a systematic review and meta-analysis.
Fassinou L, Songwa Nkeunang D, Delvaux T, Nagot N, Kirakoya-Samadoulougou F
BMC Public Health. 2024; 24(1):94.
PMID: 38183014
PMC: 10768427.
DOI: 10.1186/s12889-023-17004-9.
Adherence to option B+ PMTCT program and its predictors among HIV-positive women in Ethiopia. A systematic review and meta-analysis.
Geremew H, Geremew D, Abdisa S, Dessie A, Kassa G, Moges N
Health Sci Rep. 2023; 6(7):e1404.
PMID: 37425229
PMC: 10323164.
DOI: 10.1002/hsr2.1404.
Factors associated with poor outcomes among people living with HIV started on anti-retroviral therapy before and after implementation of "test and treat" program in Coastal Kenya.
Mwamuye I, Karanja S, Msanzu J, Adem A, Kerich M, Ngari M
PLoS One. 2022; 17(9):e0270653.
PMID: 36129876
PMC: 9491584.
DOI: 10.1371/journal.pone.0270653.
Water Access and Adherence Intention Among HIV-Positive Pregnant Women and New Mothers Receiving Antiretroviral Therapy in Zambia.
Nutor J, Marquez S, Slaughter-Acey J, Hoffmann T, DiMaria-Ghalili R, Momplaisir F
Front Public Health. 2022; 10:758447.
PMID: 35433591
PMC: 9010721.
DOI: 10.3389/fpubh.2022.758447.
Prevalence of depression among HIV-positive pregnant women and its association with adherence to antiretroviral therapy in Addis Ababa, Ethiopia.
Abebe W, Gebremariam M, Molla M, Teferra S, Wissow L, Ruff A
PLoS One. 2022; 17(1):e0262638.
PMID: 35051244
PMC: 8775187.
DOI: 10.1371/journal.pone.0262638.
The National Evaluation of Malawi's PMTCT Program (NEMAPP) study: 24-month HIV-exposed infant outcomes from a prospective cohort study.
van Lettow M, Tippett Barr B, van Oosterhout J, Schouten E, Jahn A, Kalua T
HIV Med. 2021; 23(6):573-584.
PMID: 34970836
PMC: 9303195.
DOI: 10.1111/hiv.13209.
HIV Positive Pregnant Mothers' Perceptions and Experiences Regarding the Prevention of Mother-to-Child Transmission, Option B+ Program.
Mbatha T, Dube A
J Patient Exp. 2021; 8:23743735211065272.
PMID: 34901413
PMC: 8655469.
DOI: 10.1177/23743735211065272.
Level of adherence to option B plus PMTCT and associated factors among HIV positive pregnant and lactating women in public health facilities of Hawassa city, Southern Ethiopia.
Abdisa S, Tenaw Z
PLoS One. 2021; 16(8):e0255808.
PMID: 34352020
PMC: 8341661.
DOI: 10.1371/journal.pone.0255808.
Examining the relationship between interpersonal support and retention in HIV care among HIV+ nursing mothers in Uganda.
Nutor J, Agbadi P, Hoffmann T, Anguyo G, Camlin C
BMC Res Notes. 2021; 14(1):224.
PMID: 34082834
PMC: 8176692.
DOI: 10.1186/s13104-021-05639-z.
What influences uptake and early adherence to Option B+ (lifelong antiretroviral therapy among HIV positive pregnant and breastfeeding women) in Central Uganda? A mixed methods study.
Mukose A, Bastiaens H, Makumbi F, Buregyeya E, Naigino R, Musinguzi J
PLoS One. 2021; 16(5):e0251181.
PMID: 33951109
PMC: 8099116.
DOI: 10.1371/journal.pone.0251181.
Predictors of adherence to option B+ approach for the prevention of mother to child transmission of human immunodeficiency virus in Abuja, 2017.
Dada A, Abubakar A, Bashorun A, Nguku P, Oladimeji A
Pan Afr Med J. 2021; 38:54.
PMID: 33854683
PMC: 8017365.
DOI: 10.11604/pamj.2021.38.54.16690.
Level of Good Adherence on Option B+ PMTCT and Associated Factors Among HIV Positive Pregnant and Lactating Mothers in Public Health Facilities of Ilu Abba Bor and Buno Bedele Zones, Oromia Regional State, Southwestern Ethiopia, 2018.
Asefa E, Dirirsa D
HIV AIDS (Auckl). 2020; 12:789-798.
PMID: 33273864
PMC: 7708262.
DOI: 10.2147/HIV.S283184.
The magnitude of adherence to option B plus program and associated factors among women in eastern African countries: a systematic review and meta-analysis.
Tsegaye R, Etafa W, Wakuma B, Mosisa G, Mulisa D, Tolossa T
BMC Public Health. 2020; 20(1):1812.
PMID: 33246437
PMC: 7693523.
DOI: 10.1186/s12889-020-09903-y.
Adherence to Option B Care for the Prevention of Mother-to-Child Transmission Among Pregnant Women in Ethiopia.
Wondimu F, Yetwale F, Admassu E, Binu W, Bulto G, Lake G
HIV AIDS (Auckl). 2020; 12:769-778.
PMID: 33239922
PMC: 7682779.
DOI: 10.2147/HIV.S282463.